Clinical and Psychological Assessment of Patients With Rheumatoid Arthritis and Fibromyalgia

Chao Gao, Hua Zhong, Lihong Chen, Li Wang, Hong Yao, Xiaowei Huang, Yubo Jia, Chun Li, Tian LiuResearch Square 2021 · DOI

Introduction

Rheumatoid Arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and potential systemic damage. Fibromyalgia (FM) is a separate chronic disorder defined by widespread musculoskeletal pain, fatigue, and sleep disturbances, but lacking the inflammatory markers typical of RA. When these conditions coexist, they present a significant diagnostic challenge. The subjective nature of FM pain can inflate RA disease activity scores, potentially leading to clinical overtreatment with immunosuppressants. This study investigates the clinical and psychological profiles of RA patients with concurrent FM in a real-world Chinese clinical setting.

Methods

A cross-sectional study was conducted at Peking University People’s Hospital, involving 202 RA inpatients between December 2018 and June 2019. Patients were classified for FM using the 1990 American College of Rheumatology (ACR) criteria.

The researchers employed several validated instruments:

  • Disease Activity Score in 28 Joints (DAS-28): Measures RA activity using tender/swollen joint counts and inflammatory markers.
  • Short Form-36 (SF-36) & Health Assessment Questionnaire (HAQ): Evaluates quality of life and functional disability.
  • Hospital Anxiety and Depression Scale (HADS): Assesses psychological status.
  • Fatigue Assessment Instrument (FAI): Quantifies multi-dimensional fatigue.
  • Pollard’s Standard: A screening tool where FM is suspected if the number of tender joints minus the number of swollen joints is $\ge$ 7.

Results

Of the 202 patients, 42 (20.8%) met the criteria for concurrent FM.

  • Disease Activity: The RA-FM group showed significantly higher DAS-28 scores (6.0 vs. 4.4, P=0.011).
  • Joint Counts: While Tender Joint Counts (TJC) were markedly higher in the RA-FM group (16.5 vs. 4.5, P<0.001), Swollen Joint Counts (SJC) showed no significant difference between the groups.
  • Inflammatory Markers: Objective markers such as Erythrocyte Sedimentation Rate (ESR) and C-reactive protein (CRP) levels were nearly identical between groups, indicating that the higher DAS-28 in RA-FM patients was driven by pain perception rather than increased systemic inflammation.
  • Psychological and Functional Status: RA-FM patients reported significantly higher anxiety (10 vs. 4) and depression (12 vs. 6) scores. They also experienced more fatigue (88.1% vs. 50.6%) and lower quality of life (SF-36 scores: 28.6 vs. 58.2).

Discussion

The coexistence of FM in RA patients creates a "subjectivity trap." Because the DAS-28 score relies heavily on tender joint counts, the increased pain sensitivity of FM patients can lead to an overestimation of RA disease activity. This study confirms that while RA-FM patients appear to have more severe disease based on composite scores, their objective inflammatory markers do not reflect this.

The high prevalence of anxiety and depression in the RA-FM group suggests a psychological feedback loop where chronic pain and mental health issues exacerbate one another. This highlights the need for a holistic treatment approach that addresses both the inflammatory aspects of RA and the central pain processing issues of FM.

Pollard’s standard proved to be a highly sensitive (95.2%) screening tool, making it useful for identifying patients who require further FM evaluation, although its lower specificity (52.6%) means it cannot be used for definitive diagnosis.

Conclusion and Limitations

Concurrent FM significantly impacts the clinical presentation and quality of life of RA patients. Clinicians should consider the possibility of FM when RA patients fail to reach remission despite low inflammatory markers.

Limitations of this study include its single-center inpatient focus and the use of subjective fatigue measures. Future longitudinal research is needed to evaluate the effectiveness of non-pharmacological interventions, such as psychotherapy and exercise, in this specific patient population.

Summary updated

Abstract

<title>Abstract</title> ObjectiveThis study aimed to assess the clinical features as well as the functional and psychological status of patients with rheumatoid arthritis and fibromyalgia in a real-world setting in China.MethodsA total of 202 inpatients with rheumatoid arthritis from the Department of Rheumatology and Immunology at Peking University People’s Hospital were enrolled between December 2018 and April 2019. These inpatients were assessed for the presence of fibromyalgia using the 1990 American College of Rheumatology’s classification criteria for fibromyalgia. Disease activity and functional and psychological status were assessed using the Disease Activity Score in 28 Joints (DAS-28), Short Form-36 health survey questionnaire (SF-36), Health Assessment Questionnaire (HAQ), Hospital Anxiety and Depression Scale, and Visual Analog Scale.ResultsOf 202 patients with rheumatoid arthritis, 42 (20.8%) had concurrent fibromyalgia. Compared to patients without fibromyalgia, those with rheumatoid arthritis and fibromyalgia had higher DAS-28 scores (6.0 vs. 4.4, P=0.011) and notably higher tender joint counts (16.5 vs. 4.5, P&lt;0.001). Patients with rheumatoid arthritis and fibromyalgia had worse HAQ scores (1.24 vs. 0.66, P&lt;0.001) and lower SF-36 scores (28.6 vs. 58.2, P&lt;0.001). Additionally, patients with rheumatoid arthritis and fibromyalgia experienced more fatigue (88.1% vs. 50.6%, P&lt;0.001) and had higher anxiety (10 vs. 4, P&lt;0.001) and depression scores (12 vs. 6, P&lt;0.001). No significant differences in erythrocyte sedimentation rate, C-reactive protein concentration, morning stiffness period, or swollen joint counts were identified between the groups.ConclusionsPatients with rheumatoid arthritis and fibromyalgia had higher disease activity, worse functional and psychological status, and poorer quality of life. DAS-28 scores may have been overestimated in these patients. When patients with rheumatoid arthritis do not achieve remission, the possibility of fibromyalgia should be considered.
BibTeX
@inproceedings{gao2021clinical,
  author = {Chao Gao and Hua Zhong and Lihong Chen and Li Wang and Hong Yao and Xiaowei Huang and Yubo Jia and Chun Li and Tian Liu},
  title = {{Clinical and Psychological Assessment of Patients With Rheumatoid Arthritis and Fibromyalgia}},
  booktitle = {Research Square},
  year = {2021},
  doi = {10.21203/rs.3.rs-661343/v1},
}
Figure